Anti-PDL1 Immunotherapy as a Radiosensitizer on Treating Advanced Recurrent Oropharyngeal Squamous Cell Carcinoma. Pan YA, Su NW, Leu YS. Ear Nose Throat J 2021;100.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pan YA, Su NW, Leu YS. Anti-PDL1 Immunotherapy as a Radiosensitizer on Treating Advanced Recurrent Oropharyngeal Squamous Cell Carcinoma. Ear Nose Throat J 2021;100.
PMID: 31690109